AlphaMark Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.2M | Buy |
2,308
+72
| +3% | +$37.5K | 0.52% | 42 |
|
|
2024
Q3 | $1.38M | Buy |
2,236
+22
| +1% | +$13.6K | 0.48% | 41 |
|
|
2024
Q2 | $1.22M | Buy |
2,214
+12
| +0.5% | +$6.63K | 0.43% | 40 |
|
|
2024
Q1 | $1.28M | Sell |
2,202
-102
| -4% | -$59.3K | 0.45% | 39 |
|
|
2023
Q4 | $1.22M | Buy |
2,304
+45
| +2% | +$23.9K | 0.46% | 40 |
|
|
2023
Q3 | $1.14M | Buy |
2,259
+15
| +0.7% | +$7.59K | 0.49% | 41 |
|
|
2023
Q2 | $1.17M | Sell |
2,244
-463
| -17% | -$242K | 0.54% | 42 |
|
|
2023
Q1 | $1.56M | Buy |
2,707
+91
| +3% | +$52.4K | 0.7% | 37 |
|
|
2022
Q4 | $1.44M | Sell |
2,616
-120
| -4% | -$66.1K | 0.72% | 37 |
|
|
2022
Q3 | $1.39M | Sell |
2,736
-7
| -0.3% | -$3.55K | 0.69% | 36 |
|
|
2022
Q2 | $1.49M | Buy |
2,743
+15
| +0.5% | +$8.15K | 0.69% | 37 |
|
|
2022
Q1 | $1.61M | Sell |
2,728
-225
| -8% | -$133K | 0.6% | 42 |
|
|
2021
Q4 | $1.97M | Sell |
2,953
-3
| -0.1% | -$2K | 0.69% | 35 |
|
|
2021
Q3 | $1.69M | Buy |
2,956
+17
| +0.6% | +$9.71K | 0.61% | 41 |
|
|
2021
Q2 | $1.48M | Sell |
2,939
-19
| -0.6% | -$9.59K | 0.54% | 46 |
|
|
2021
Q1 | $1.35M | Sell |
2,958
-649
| -18% | -$296K | 0.52% | 47 |
|
|
2020
Q4 | $1.68M | Sell |
3,607
-3,465
| -49% | -$1.61M | 0.64% | 39 |
|
|
2020
Q3 | $3.12M | Sell |
7,072
-1,816
| -20% | -$802K | 1.29% | 21 |
|
|
2020
Q2 | $3.22M | Sell |
8,888
-175
| -2% | -$63.4K | 1.39% | 24 |
|
|
2020
Q1 | $2.57M | Sell |
9,063
-237
| -3% | -$67.2K | 1.42% | 25 |
|
|
2019
Q4 | $3.02M | Buy |
9,300
+128
| +1% | +$41.6K | 1.26% | 29 |
|
|
2019
Q3 | $2.67M | Buy |
9,172
+171
| +2% | +$49.8K | 1.16% | 35 |
|
|
2019
Q2 | $2.64M | Buy |
9,001
+200
| +2% | +$58.7K | 1.16% | 36 |
|
|
2019
Q1 | $2.41M | Buy |
+8,801
| New | +$2.41M | 1.02% | 43 |
|